Results 141 to 150 of about 26,703 (203)

AQP4-IgG and mood disorders: Case series of neuromyelitis optica spectrum disorder. [PDF]

Brain Behav Immun Health
Xu Q, Han Y, Gao S, Wang S, Lu Y, Su KP, Xu X.   +6 more
europepmc   +1 more source

Neuromyelitis Optica Spectrum Disorder Initially Presenting With Meningitis-Like Symptoms: A Case Report. [PDF]

Cureus
Kubo Y, Nishimura T, Sakuragi C, Yoshimura J, Okubo S.   +4 more
europepmc   +1 more source

Hearing Loss in Neuromyelitis Optica Spectrum Disorder: Case Report and Systematic Review. [PDF]

J Clin Med
Kalampokini S, Koutsouraki E, Psillas G, Karatzioula E, Kaffe K, Spilioti M, Kimiskidis V.   +6 more
europepmc   +1 more source

Dysregulated Tfh/B cells and their interactions in neuromyelitis optica spectrum disorder. [PDF]

Front Immunol
Wang L, Zhou L, Wang Z, ZhangBao J, Huang W, Tan H, Fan Y, Lu C, Yu J, Wang M, Lu J, Zhao C, Wang J, Quan C.   +13 more
europepmc   +1 more source

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series. [PDF]

Neurol Neuroimmunol Neuroinflamm
Rommer PS, Jiang W, Nolte JP, Mikami T, De Seze J, Sánchez P, Harel A, Alkabie S, Kaneko K, Bilodeau PA, Misu T, Kremer L, Bigaut K, Leypoldt F, Aktas O, Ringelstein M, Siffrin V, Zhang LJ, Cong H, Lowe M, Barreras P, Chen H, Piquet AL, Sotirchos ES, Kammeyer R, Zook J, Bennett JL, Berger T, Fujihara K, Levy M, Shi FD, Paul F.   +31 more
europepmc   +1 more source

Syncope in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a case series and literature review. [PDF]

Front Neurosci
Jin C, Yang Y, Song X, Sun Y, Peng Y, Wang L, Zheng X.   +6 more
europepmc   +1 more source

Neuromyelitis Optica

, 2016
  +4 more sources

Inebilizuma treatment for acute serum AQP4 - IgG neuromyelitis optica: Case report. [PDF]

Medicine (Baltimore)
Zhu SH, Liu DH, Liu Q, Chen Q, Shen Y, Yang SY, Pan BX, Yang F, Jiang PF.   +8 more
europepmc   +1 more source

To stop or not to stop: the clinical dilemma of long-term double-seronegative neuromyelitis optica therapy. [PDF]

Arq Neuropsiquiatr
Adoni T.
europepmc   +1 more source

Double-seronegative neuromyelitis optica: it is possible to interrupt treatment after 10 years of stability. [PDF]

Arq Neuropsiquiatr
Silva GD.
europepmc   +1 more source